We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Immunofluorescent Imaging/Analysis Solution Quantifies Protein Biomarkers

By LabMedica International staff writers
Posted on 30 Nov 2011
An immunofluorescent imaging and analysis solution provides an improvement on traditional immunohistochemistry.

The new product enables users to leverage the combined imaging and analysis power of Vectra 2 and AQUA technology, an image analysis system, to provide an integrated solution to advance the identification and validation of new drug targets and improve assessment of drug response.

Vectra 2 is an automated multiplexed and multispectral tissue-imaging platform. More...
AQUA technology is capable of precisely measuring protein biomarker concentration with sub-cellular resolution in tissue sections, enabling fully objective, reproducible, and automated analysis to guide drug development and therapeutic decision-making.

Caliper Life Sciences (Hopkinton, MA, USA) and HistoRx (Branford, CT, USA) collaborated on the new immunofluorescent imaging and analysis solution that will deliver objective, quantitative, and reproducible immunohistochemistry results. Caliper will distribute the integrated product in the scientific market; the two companies are also exploring collaborations in diagnostics and clinical research.

AQUAServe is new server-based queuing software designed to enable “walk-away” operation for multiple specimens while retaining the full functionality of HistoRx's flagship AQUAnalysis software.

Caliper Life Sciences, a Perkin-Elmer Company, launched the new Vectra 2 with AQUA technology, an integrated solution for quantification of protein biomarkers in tissue, at the Molecular Targets & Cancer Therapeutics meeting held from November 12-16, 2011, in San Francisco (CA, USA)

"The Vectra 2 with AQUA technology represents a significant move forward for those interested in digital pathology with both brightfield and fluorescent capabilities," said Mark Gustavson, PhD, director of operations at HistoRx.

Related Links:
Caliper Life Sciences
HistoRx


Gold Member
Neonatal Heel Incision Device
Tenderfoot
Online QC Software
Acusera 24•7
Hematology Consumables
Bioblood Devices
POC Immunoassay Analyzer
Procise DX
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: New findings show unique pathogen‑directed antibody patterns are already present years ahead of a formal diagnosis of inflammatory bowel disease (Image Credit: iStock)

Antibody Profiling Identifies Preclinical Inflammatory Bowel Disease Years Before Diagnosis

Inflammatory bowel disease often develops after a prolonged symptom-free period, complicating timely recognition and clinical intervention. Limited understanding of immune activity during this silent phase... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.